HIV-1 Infection
Showing 26 - 50 of 178
HIV-1 Infection Trial in Chapel Hill (VRC07-523LS, Vorinostat (VOR))
Completed
- HIV-1 Infection
- VRC07-523LS
- Vorinostat (VOR)
-
Chapel Hill, North CarolinaUniversity of North Carolina Health Care
Nov 4, 2021
Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1
Terminated
- HIV-1 Infection
-
Sydney, New South Wales, AustraliaSt Vincent's Hospital
Oct 31, 2021
HIV-1 Infection Trial (Doravirine/lamivudine/tenofovir disoproxil fumarate)
Completed
- HIV-1 Infection
- Doravirine/lamivudine/tenofovir disoproxil fumarate
- (no location specified)
Oct 7, 2021
HIV-1 Infection Trial in Worldwide (Etoposide (ET), Bleomycin and Vincristine (BV), Paclitaxel (PTX))
Completed
- HIV-1 Infection
- Etoposide (ET)
- +3 more
-
Rio de Janeiro, Brazil
- +10 more
Sep 24, 2021
HIV-1 Infection Trial in Yaoundé (Dolutegravir 50 mg, Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg, Efavirenz 400
Completed
- HIV-1 Infection
- Dolutegravir 50 mg
- +2 more
-
Yaoundé, Cameroon
- +2 more
Aug 26, 2021
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Completed
- HIV-1 Infection
- Antiretroviral treatment pause
-
Los Angeles, California
- +17 more
Jul 31, 2021
HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)
HIV-1 Infection Trial in Puerto Rico, United States (atorvastatin, for atorvastin)
Completed
- HIV-1 Infection
- atorvastatin
- placebo for atorvastin
-
Birmingham, Alabama
- +30 more
Jul 31, 2021
HIV-1 Infection Trial in United States (Emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
Completed
- HIV-1 Infection
- Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
-
Birmingham, Alabama
- +18 more
Jul 31, 2021
HIV-1 Infection Trial in Montpellier (HIV DNA)
Completed
- HIV-1 Infection
- HIV DNA
-
Montpellier, FranceUniversity hospital Montpellier
Jul 5, 2021
Fixed Dose Combination of Lopinavir/Ritonavir in Human
Terminated
- HIV-1 Infection
-
Kazan, Tatarstan, Respublika, Russian Federation
- +9 more
Jul 1, 2021
HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)
Unknown status
- HIV
- +2 more
- Pegylated Interferon alpha 2b (peg-IFN-α2b)
- 3BNC117 + 10-1074
-
Philadelphia, Pennsylvania
- +1 more
Jun 22, 2021
HIV-1 Infection Trial in United States (Vesatolimod, Placebo, ART)
HIV-1 Infection Trial in Paris (Cal-1 (LVsh5/C46) drug product)
Recruiting
- HIV-1 Infection
- Cal-1 (LVsh5/C46) drug product
-
Paris, FranceHôpital Saint Louis
Apr 13, 2021
HIV-1 Infection Trial in United States (Lenacapavir, Placebo, B/F/TAF)
Detection of Delayed Adverse Events in Cal-1 Recipients
Active, not recruiting
- HIV-1 Infection
- Receipt of Cal-1 Modified Hematopoietic Cellular Products
- Blood tests
-
Los Angeles, California
- +1 more
Feb 3, 2021
HIV-1 Infection, Neuropathic Pain Trial in Worldwide (pregabalin (Lyrica))
Terminated
- HIV-1 Infection
- Neuropathic Pain
- pregabalin (Lyrica)
-
Phoenix, Arizona
- +28 more
Jan 26, 2021